Zhende Medical (China) Technical Analysis
| 603301 Stock | 22.64 0.06 0.27% |
As of the 26th of November, Zhende Medical maintains the Market Risk Adjusted Performance of (0.28), downside deviation of 2.55, and Mean Deviation of 1.46. Zhende Medical technical analysis makes it possible for you to employ past prices and volume data with the intention to determine a pattern that calculates the direction of the company's future prices.
Zhende Medical Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Zhende, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ZhendeZhende |
Zhende Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Zhende Medical Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Zhende Medical volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Zhende Medical Trend Analysis
Use this graph to draw trend lines for Zhende Medical Co. You can use it to identify possible trend reversals for Zhende Medical as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Zhende Medical price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Zhende Medical Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Zhende Medical Co applied against its price change over selected period. The best fit line has a slop of 0.07 , which means Zhende Medical Co will continue generating value for investors. It has 122 observation points and a regression sum of squares at 160.37, which is the sum of squared deviations for the predicted Zhende Medical price change compared to its average price change.About Zhende Medical Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Zhende Medical Co on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Zhende Medical Co based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Zhende Medical price pattern first instead of the macroeconomic environment surrounding Zhende Medical. By analyzing Zhende Medical's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Zhende Medical's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Zhende Medical specific price patterns or momentum indicators. Please read more on our technical analysis page.
Zhende Medical November 26, 2024 Technical Indicators
Most technical analysis of Zhende help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Zhende from various momentum indicators to cycle indicators. When you analyze Zhende charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0602 | |||
| Market Risk Adjusted Performance | (0.28) | |||
| Mean Deviation | 1.46 | |||
| Semi Deviation | 2.18 | |||
| Downside Deviation | 2.55 | |||
| Coefficient Of Variation | 1428.24 | |||
| Standard Deviation | 2.34 | |||
| Variance | 5.46 | |||
| Information Ratio | 0.015 | |||
| Jensen Alpha | 0.2167 | |||
| Total Risk Alpha | (0.21) | |||
| Sortino Ratio | 0.0137 | |||
| Treynor Ratio | (0.29) | |||
| Maximum Drawdown | 19.14 | |||
| Value At Risk | (2.60) | |||
| Potential Upside | 3.13 | |||
| Downside Variance | 6.52 | |||
| Semi Variance | 4.77 | |||
| Expected Short fall | (1.49) | |||
| Skewness | (0.25) | |||
| Kurtosis | 7.51 |
Complementary Tools for Zhende Stock analysis
When running Zhende Medical's price analysis, check to measure Zhende Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zhende Medical is operating at the current time. Most of Zhende Medical's value examination focuses on studying past and present price action to predict the probability of Zhende Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zhende Medical's price. Additionally, you may evaluate how the addition of Zhende Medical to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world |